LICAVAL: Combination therapy in acute and maintenance treatment of bipolar disorder

Trials

Volumn 11, Issue , 2010, Pages

  Campos, Rodolfo N ^a   Costa, Luis F ^a   Bio, Danielle S ^a   Soeiro de Souza, Márcio G ^a   Garcia, Carla R L ^a   Demétrio, Frederico N ^a   Moreno, Doris H ^a   Moreno, Ricardo A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LITHIUM; VALPROIC ACID; LITHIUM CARBONATE; TRANQUILIZER;

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CLINICAL EVALUATION; CLINICAL PRACTICE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG TOLERABILITY; FOLLOW UP; HUMAN; HYPOMANIA; MAINTENANCE THERAPY; MANIA; MIXED MANIA AND DEPRESSION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; TREATMENT DURATION; ACUTE DISEASE; ADOLESCENT; BIPOLAR DISORDER; COGNITION; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; QUALITY OF LIFE; SOCIAL BEHAVIOR;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; COGNITION; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM CARBONATE; QUALITY OF LIFE; SOCIAL BEHAVIOR; VALPROIC ACID; YOUNG ADULT;

EID: 77953710809     PISSN: 17456215     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-11-72     Document Type: Article

References (22)

1. Goldberg JF. Optimizing treatment outcomes in bipolar disorder under ordinary conditions. J Clin Psychiatry 2008, 69(Suppl 3):11-9.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Text Revision 2000, Washington DC, American Psychiatric Association, Fourth, American Psychiatric Association.
3. Beyer JL. An evidence-based medicine strategy for achieving remission in bipolar disorder. J Clin Psychiatry 2008, 69(Suppl 3):31-7.
4. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, Ketter TA, Miklowitz DJ, Otto MW, Gyulai L, Reilly-Harrington NA, Nierenberg AA, Sachs GS, Thase ME. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006, 163(2):217-24. 10.1176/appi.ajp.163.2.217, 16449474.
5. Goodwin FK. Rationale for long-term treatment of bipolar disorder and evidence for long-term lithium treatment. J Clin Psychiatry 2002, 63(Suppl 10):5-12.
6. Gershon S, Chengappa KN, Malhi GS. Lithium specificity in bipolar illness: a classic agent for the classic disorder. Bipolar Disord 2009, 11(Suppl 2):34-44. 10.1111/j.1399-5618.2009.00709.x, 19538684.
7. Pérez-Ceballos MA, Vega-Gil N, Sánchez MB, Armijo JA. Use of antiepileptic drugs in bipolar disorder. Actas Esp Psiquiatr 2006, 34(1):55-64.
8. Bowden CL. Anticonvulsants in bipolar disorders: current research and practice and future directions. Bipolar Disord 2009, 11(Suppl 2):20-33. 10.1111/j.1399-5618.2009.00708.x, 19538683.
9. Weisler RH, Cutler AJ, Ballenger JC, Post RM, Ketter TA. The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials. CNS Spectr 2006, 11(10):788-99.
10. Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010, 8(1):18. 10.1186/1741-7015-8-18, 2860339, 20334633.
11. Cohen J. Statistical power analysis for the behavior sciences. 1988, Hillsdale, NJ: Erlbaum, 2.
12. Hirschfeld RMA, Calabrese JR, Frye MA, Lavori PW, Sachs G, Tase M, Wagner KD. Defining the clinical course of bipolar disorder: response, remission, relapse, recurrence, and roughening. Psychopharmacol Bull 2007, 40(3):7-14.
13. Bauer M, Alda M, Priller J, Young LT, . International Group For The Study Of Lithium Treated Patients (IGSLI) Implications of the neuroprotective effects of lithium for the treatment of bipolar and neurodegenerative disorders. Pharmacopsychiatry 2003, 36(Suppl 3):S250-4. International Group For The Study Of Lithium Treated Patients (IGSLI).
14. Tohen M, Frank E, Bowden CL, Colom F, Ghaemi SN, Yatham LN, Malhi GS, Calabrese JR, Nolen WA, Vieta E, Kapczinski F, Goodwin GM, Suppes T, Sachs GS, Chengappa KR, Grunze H, Mitchell PB, Kanba S, Berk M. The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders. Bipolar Disord 2009, 11(5):453-73. 10.1111/j.1399-5618.2009.00726.x, 19624385.
15. Vieta PE, Torrent FC, Martínez-Arán A, Colom VF, Reinares GM, Benabarre HA, Comes FM, Goikolea AJM. A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M. Actas Esp Psiquiatr 2002, 30(5):301-4.
16. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987, 334:1-100. 10.1111/j.1600-0447.1987.tb10566.x, 2887090.
17. The WHOQOL Group What Quality of Life?. 1996, 354-56. World Health Forum. WHO: Geneva, The WHOQOL Group.
18. Weissman MM, Bothwell S. Assessment of social adjustment by patient self-report. Arch Gen Psychiatry 1976, 33:1111-5.
19. Fleck MPA. O instrumento de avaliação de qualidade de vida da Organização Mundial da Saúde (WHOQOL-100): características e perspectivas. Ciênc. Saúde Coletiva 2000, 5(1):33-38.
20. Gorenstein C, Andrade L, Moreno RA, Bernik MA, Nicastri S, Cordás TA, Camargo AP. Escala de auto-avaliação de adequação social: validação da versão em língua portuguesa. Escalas de avaliação clínica em psiquiatria e psicofarmacologia. São Paulo: Lemos 2000, 401-414. Gorenstein C, Andrade LHSG, Zuardi AW.
21. Spreen O, Strauss E. A Compendium of neuropsychological tests. 1998, Oxford: Oxford University Press.
22. Wechsler D. Wechsler Abbreviated Scale of Inteligence. 1999, New York: Psychological Corporation.